ImmuCell Corporation (ICCC)
NASDAQ · Healthcare
ImmuCell Corporation Total Liabilities 2017–2025
ImmuCell Corporation annual/quarterly total liabilities history from 2017 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- ImmuCell Corporation total liabilities for the quarter ending December 31, 2025 were 15.5M, a 11.97% decrease year-over-year.
- ImmuCell Corporation total liabilities for 2025 were 15.5M, a 11.97% decrease from 2024.
- ImmuCell Corporation total liabilities for 2024 were 17.6M, a 6.55% decrease from 2023.
- ImmuCell Corporation total liabilities for 2023 were 18.8M, a 29.93% increase from 2022.
- ImmuCell Corporation total liabilities for 2022 were 14.5M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| ImmuCell Corporation Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $15 |
| 2024 | $18 |
| 2023 | $19 |
| 2022 | $14 |
| 2021 | $12 |
| 2020 | $12 |
| 2019 | $10 |
| 2018 | $11 |
| 2017 | $11 |
| ImmuCell Corporation Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $15 |
| 2024-12-31 | $18 |
| 2023-12-31 | $19 |
| 2022-12-31 | $14 |
| 2021-12-31 | $12 |
| 2020-12-31 | $12 |
| 2019-12-31 | $10 |
| 2018-12-31 | $11 |
| 2017-12-31 | $11 |
ImmuCell Corporation Total Liabilities — FAQ
ImmuCell Corporation (ICCC) total liabilities over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ICCC's total liabilities history?
The chart and table above show ImmuCell Corporation's total liabilities by year and by quarter, including the growth rate.